Hasil Pencarian - Yi‐long Wu

Perbaiki Hasil
  1. 1
    Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review

    Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a review oleh Shan Su, Yi-Long Wu

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Developing CSCO Lung Cancer Practice Guidelines Stratified by Resource Availability and Treatment Value

    Developing CSCO Lung Cancer Practice Guidelines Stratified by Resource Availability and Treatment Value oleh Qing Zhou, Yi-Long Wu

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence

    Afatinib in the first-line treatment of epidermal-growth-factor-receptor mutation-positive non-small cell lung cancer: a review of the clinical evidence oleh E-E Ke, Yi-Long Wu

    Diterbitkan 2016-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China

    Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China oleh Si-Yang Liu, Yi-Long Wu

    Diterbitkan 2017-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer

    The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer oleh Yi-Chen Zhang, Qing Zhou, Yi-Long Wu

    Diterbitkan 2017-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer

    Novel systemic therapies in the management of tyrosine kinase inhibitor-pretreated patients with epidermal growth factor receptor-mutant non-small-cell lung cancer oleh Yang-Si Li, Guang-Ling Jie, Yi-Long Wu

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Molecular residual disease: A new clue for individualized approach in non‐small cell lung cancer

    Molecular residual disease: A new clue for individualized approach in non‐small cell lung cancer oleh Jia‐Tao Zhang, Wen‐Zhao Zhong, Yi‐Long Wu

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Emerging therapies for non-small cell lung cancer

    Emerging therapies for non-small cell lung cancer oleh Chao Zhang, Natasha B. Leighl, Yi-Long Wu, Wen-Zhao Zhong

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    In Vivo Effects of Free Form Astaxanthin Powder on Anti-Oxidation and Lipid Metabolism with High-Cholesterol Diet.

    In Vivo Effects of Free Form Astaxanthin Powder on Anti-Oxidation and Lipid Metabolism with High-Cholesterol Diet. oleh Yung-Yi Chen, Pei-Chi Lee, Yi-Long Wu, Li-Yun Liu

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Potential benefited population for sublobar resection

    Potential benefited population for sublobar resection oleh Rui Fu, MD, Yi-Long Wu, MD, Wen-Zhao Zhong, MD, PhD

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Applications of Circulating Tumor DNA in Immune Checkpoint Inhibition: Emerging Roles and Future Perspectives

    Applications of Circulating Tumor DNA in Immune Checkpoint Inhibition: Emerging Roles and Future Perspectives oleh Chang Lu, Yi-Chen Zhang, Zhi-Hong Chen, Qing Zhou, Yi-Long Wu

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Predictive value of intra‐tumoural TCRβ rearrangements in precisely selecting adjuvant therapy for EGFR‐mutant non‐small‐cell lung cancer

    Predictive value of intra‐tumoural TCRβ rearrangements in precisely selecting adjuvant therapy for EGFR‐mutant non‐small‐cell lung cancer oleh Cunte Chen #, Si‐Yang Maggie Liu #, Yi‐Long Wu, Si‐Yang Liu, Yangqiu Li

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysisCentral MessagePerspective

    Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysisCentral MessagePerspective oleh Chao Zhang, MD, Hui-Zhao Hong, MD, Yi-Long Wu, MD, Wen-Zhao Zhong, MD, PhD

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study

    Recursive partitioning analysis of patients with oligometastatic non-small cell lung cancer: a retrospective study oleh Jia-Tao Zhang, Si-Yang Liu, Hong-Hong Yan, Yi-Long Wu, Qiang Nie, Wen-Zhao Zhong

    Diterbitkan 2019-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Emerging evidence and treatment paradigm of non-small cell lung cancer

    Emerging evidence and treatment paradigm of non-small cell lung cancer oleh Si-Yang Maggie Liu, Mei-Mei Zheng, Yi Pan, Si-Yang Liu, Yangqiu Li, Yi-Long Wu

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy

    Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy oleh Jian Su, Yi-Long Wu, Xu-Chao Zhang, Kai Yin, Si-Yang Liu, Li-Xu Yan, Xue-Ning Yang

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives

    Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives oleh Wen‐Fang Tang, Rui Fu, Yi Liang, Jie‐Shan Lin, Zhen‐Bin Qiu, Yi‐Long Wu, Wen‐Zhao Zhong

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancer

    A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancer oleh Yichao Han, Si-Yang Maggie Liu, Si-Yang Maggie Liu, Runsen Jin, Wangyang Meng, Yi-Long Wu, Hecheng Li

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer

    Mutational landscape and characteristics of ERBB2 in non‐small cell lung cancer oleh Xue‐Wu Wei, Xin Gao, Xu‐Chao Zhang, Jin‐Ji Yang, Zhi‐Hong Chen, Yi‐Long Wu, Qing Zhou

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer

    Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer oleh Si-Yang Maggie Liu, Cunte Chen, Yi-Kai Zhang, Wen-Zhao Zhong, Yi-Long Wu, Si-Yang Liu, Yangqiu Li

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: